Clinical trial
An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the…
NCT00307632 · Janssen-Cilag Farmaceutica Ltda., Industry · Completed
Key facts
| NCT number | NCT00307632 |
|---|---|
| Title | An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol |
| Official title | An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol |
| Lead sponsor | Janssen-Cilag Farmaceutica Ltda., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | Norelgestromine (NLGM)/ethinyl estradiol (EE) |
| Enrollment | 580 |
| Start date | Feb 1, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Mar 28, 2006 |
| Last update posted | May 15, 2014 |
| Countries | Brazil, Mexico |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: